JP2002502812A - 胃腸管の慢性炎症疾患の治療 - Google Patents

胃腸管の慢性炎症疾患の治療

Info

Publication number
JP2002502812A
JP2002502812A JP2000530199A JP2000530199A JP2002502812A JP 2002502812 A JP2002502812 A JP 2002502812A JP 2000530199 A JP2000530199 A JP 2000530199A JP 2000530199 A JP2000530199 A JP 2000530199A JP 2002502812 A JP2002502812 A JP 2002502812A
Authority
JP
Japan
Prior art keywords
budesonide
oil
dose
suspension
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000530199A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002502812A5 (enExample
Inventor
ジョエル・ボロニック
アラン・スチュアート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2002502812A publication Critical patent/JP2002502812A/ja
Publication of JP2002502812A5 publication Critical patent/JP2002502812A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2000530199A 1998-02-09 1998-02-09 胃腸管の慢性炎症疾患の治療 Pending JP2002502812A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002265 WO1999039699A1 (en) 1998-02-09 1998-02-09 Treatment of chronic inflammatory disorders of the gastrointestinal tract

Publications (2)

Publication Number Publication Date
JP2002502812A true JP2002502812A (ja) 2002-01-29
JP2002502812A5 JP2002502812A5 (enExample) 2005-12-22

Family

ID=22266344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000530199A Pending JP2002502812A (ja) 1998-02-09 1998-02-09 胃腸管の慢性炎症疾患の治療

Country Status (9)

Country Link
EP (1) EP1052977A4 (enExample)
JP (1) JP2002502812A (enExample)
KR (1) KR20010040646A (enExample)
CN (1) CN1149078C (enExample)
AU (1) AU735084B2 (enExample)
CA (1) CA2320087C (enExample)
IL (1) IL137598A (enExample)
SE (1) SE0002831L (enExample)
WO (1) WO1999039699A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008099615A1 (ja) * 2007-02-16 2010-05-27 あすか製薬株式会社 微粒子油性懸濁液を含む医薬組成物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
MD2852C2 (ro) * 2005-03-28 2006-04-30 Георге АНГЕЛИЧ Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2705681C (en) 2007-11-13 2013-06-18 Meritage Pharma, Inc. Corticosteroid compositions
US20090123390A1 (en) 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
JP3342484B2 (ja) * 1991-12-18 2002-11-11 アストラ・アクチエボラーグ 新規な配合
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
WO1998005310A1 (fr) * 1996-08-02 1998-02-12 Hisamitsu Pharmaceutical Co., Inc. Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale
KR100219918B1 (ko) * 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008099615A1 (ja) * 2007-02-16 2010-05-27 あすか製薬株式会社 微粒子油性懸濁液を含む医薬組成物
JP2010120974A (ja) * 2007-02-16 2010-06-03 Aska Pharmaceutical Co Ltd 微粒子油性懸濁液を含む医薬組成物
US8309138B2 (en) 2007-02-16 2012-11-13 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension

Also Published As

Publication number Publication date
EP1052977A1 (en) 2000-11-22
IL137598A (en) 2005-09-25
EP1052977A4 (en) 2006-07-12
IL137598A0 (en) 2001-07-24
CN1284869A (zh) 2001-02-21
SE0002831D0 (sv) 2000-08-07
AU6320098A (en) 1999-08-23
CA2320087C (en) 2006-12-19
CN1149078C (zh) 2004-05-12
KR20010040646A (ko) 2001-05-15
CA2320087A1 (en) 1999-08-12
AU735084B2 (en) 2001-06-28
WO1999039699A1 (en) 1999-08-12
SE0002831L (sv) 2000-09-28

Similar Documents

Publication Publication Date Title
US5863910A (en) Treatment of chronic inflammatory disorders of the gastrointestinal tract
McKeage et al. Budesonide (Entocort® EC Capsules) A Review of its Therapeutic Use in the Management of Active Crohn’s Disease in Adults
ES2991544T3 (es) Ketamina para el tratamiento de síntomas relacionados con la menstruación
US11083700B2 (en) Butyrate salts for use in inflammatory diseases
JP6796132B2 (ja) 液体剤形中の薬学的活性化合物放出性多層微小粒子
WO2012079092A2 (en) Testosterone undecanoate compositions
JPH07501343A (ja) 経口用１α−ヒドロキシプレビタミンＤ
JP2002080398A (ja) ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物
JPH11503160A (ja) プロトンポンプ阻害剤を含有する医薬組成物
JP2009526087A (ja) 悪液質の予防および処置のための組成物および方法
JP2002502812A (ja) 胃腸管の慢性炎症疾患の治療
US20180110817A1 (en) Maca compositions and methods of use
JP2017200942A (ja) 副腎機能障害の治療
AU2020239829A1 (en) Oral rapamycin nanoparticle preparations and use
CN111419800B (zh) 用于治疗红斑狼疮的药物制剂及其制备方法
JP2020526512A (ja) 新規のセクニダゾールの軟ゼラチンカプセル製剤及びその使用
RU2485956C2 (ru) Новая композиция для лечения побочных эффектов противораковой терапии
CN100594933C (zh) 抗肥胖剂和健康食品
JPH09151197A (ja) 自己免疫疾患治療薬
JP2008526773A5 (enExample)
Moses et al. Inflammatory bowel disease: 1. Origins, presentation, and course
CN112704730A (zh) 预防或治疗肠易激综合征的药物组合
Ballinger Management of growth retardation in the young patient with Crohn’s disease
CN1138826A (zh) 5-硝基咪唑衍生物微粒
US20110021591A1 (en) Phenylbutazone carrier formulation showing increased bioactivity in animals

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050128

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081201

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090623